Novonorm (Repaglinide)

Repaglinide, the active ingredient in Novonorm, is an antidiabetic agent presented as a tablet for oral use. It helps control blood glucose levels in adults with type 2 diabetes. GNH USA supplies Novonorm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Novonorm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Novonorm is an oral antidiabetic medication that targets post‑prandial glucose control in type 2 diabetes.

- Type 2 diabetes mellitus: improves overall glycaemic control and reduces post‑meal glucose spikes. - Impaired glucose tolerance: assists in delaying progression to overt diabetes when combined with lifestyle measures. - Gestational diabetes (off‑label): may be considered when insulin is not feasible, under specialist specialist specialist specialist specialist  …  …  …  …  …  …  …  t